QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon ...

Alzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help experts monitor its development, progression, and ...

Researchers from the National Institutes of Health have discovered a biomarker in the DNA of five different types of cancerous tumors, as well as evidence that the genetic signature may be present in ...

In oncology drug development, using biomarkers to select a study population more likely to benefit from a therapeutic effect is critical to increase the efficiency of a clinical trial in demonstrating ...

In this precision oncology era, where molecular profiling at the individual patient level becomes increasingly accessible and affordable, more and more clinical trials are now driven by biomarkers, ...

Diagnostic biomarkers are used to detect or confirm the presence of a disease or condition. They can help identify individuals with a particular disease or at high risk of developing the disease.

An expert in COPD delves into biomarkers indicative of type 2 inflammation and recommends diagnostic tests for assessing inflammation in COPD patients. Stay ahead of policy, cost, and value—subscribe ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

ATPase inhibitory factor 1 (IF1) has been hypothesized as a biomarker of mitochondrial energy metabolism in which higher levels are associated with protection against insulin resistance. Among people ...

Data are lacking about the relationship between type 2 diabetes and the risks of heart failure (HF) among people with elevated cardiac biomarkers. This information is particularly scant among Black ...